178 related articles for article (PubMed ID: 30478449)
1. Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer.
Zhao L; Wang W; Xu L; Yi T; Zhao X; Wei Y; Vermeulen L; Goel A; Zhou S; Wang X
Oncogene; 2019 Mar; 38(13):2305-2319. PubMed ID: 30478449
[TBL] [Abstract][Full Text] [Related]
2. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
5. The activation of microRNA-520h-associated TGF-β1/c-Myb/Smad7 axis promotes epithelial ovarian cancer progression.
Zhang J; Liu W; Shen F; Ma X; Liu X; Tian F; Zeng W; Xi X; Lin Y
Cell Death Dis; 2018 Aug; 9(9):884. PubMed ID: 30158641
[TBL] [Abstract][Full Text] [Related]
6. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
9. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
10. Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer.
Li L; Gu H; Chen L; Zhu P; Zhao L; Wang Y; Zhao X; Zhang X; Zhang Y; Shu P
Biomed Res Int; 2019; 2019():1056431. PubMed ID: 31275959
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
12. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Yang D; Sun Y; Hu L; Zheng H; Ji P; Pecot CV; Zhao Y; Reynolds S; Cheng H; Rupaimoole R; Cogdell D; Nykter M; Broaddus R; Rodriguez-Aguayo C; Lopez-Berestein G; Liu J; Shmulevich I; Sood AK; Chen K; Zhang W
Cancer Cell; 2013 Feb; 23(2):186-99. PubMed ID: 23410973
[TBL] [Abstract][Full Text] [Related]
13. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC.
Alrashed MM; Ahmad M; Yongmei W; Xiuyeng W
J Reprod Immunol; 2021 Jun; 145():103310. PubMed ID: 33730656
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
[TBL] [Abstract][Full Text] [Related]
17. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
Sun Y; Hu L; Zheng H; Bagnoli M; Guo Y; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Ji P; Chen K; Sood AK; Mezzanzanica D; Liu J; Sun B; Zhang W
J Pathol; 2015 Jan; 235(1):25-36. PubMed ID: 25230372
[TBL] [Abstract][Full Text] [Related]
18. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
19. Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer.
Sheng M; Tong H; Lu X; Shanshan N; Zhang X; Reddy BA; Shu P
Medicine (Baltimore); 2020 Oct; 99(41):e22549. PubMed ID: 33031300
[TBL] [Abstract][Full Text] [Related]
20. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
